Birmingham, West Midlands -- (SBWIRE) -- 01/08/2014 -- Value Penny Stocks issues special report on JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO), Capstone Turbine Corporation (NASDAQ:CPST), Peregrine Pharmaceuticals (NASDAQ:PPHM), Cell Therapeutics Inc (NASDAQ:CTIC).
JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) ended its recent business day with the gain of 0.61% and closed at the price of $9.82 after opening at $9.86. The stock traded during its last trading session with the total volume of 7,061,605 shares, as compared to its average volume of 1.89 million shares. JA Solar Holdings Co., Ltd., through its subsidiaries, engages in the design, development, production, marketing, and sale of solar power products based on crystalline silicon technologies. The company’s principal products include monocrystalline and multicrystalline solar cells and modules.
For How Long JASO will Fight for Profitability? Read This Trend Analysis report
Capstone Turbine Corporation (NASDAQ:CPST) remained among the day advancers and traded with volume of 6,907,783 shares in the last session, as compared to average volume of 2.47 million shares. In comparison with 52 week range of $0.73 - $1.52, it faced lowest price of $1.41 during the last trading session whereas its day highest price was $1.47. The company’s total market capitalization is $441.64 billion, along with 309.92 million shares outstanding. Capstone Turbine Corporation engages in developing, manufacturing, marketing, and servicing microturbine technology solutions for use in stationary distributed power generation applications worldwide. The company primarily offers microturbine units, subassemblies, components, and various accessories for applications.
For How Long CPST’s Gloss will Attract Investors? Find out via this report
Peregrine Pharmaceuticals (NASDAQ:PPHM) showed 6,892,093 shares in volume during the last trading session, while the average trading volume remained 1.96 million shares. The stock kicked off its trading session at $1.69 and closed at $1.58 after declining -4.82%. Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of monoclonal antibodies focused on the treatment and diagnosis of cancer. The company’s lead product candidates in development include Bavituximab, a phosphatidylserine (PS) targeting agent that completed Phase IIb second-line non-small cell lung cancer trial for the treatment of solid tumors.
Why Should Investors Buy PPHM After the Recent Fall? Just Go Here and Find Out
Cell Therapeutics Inc (NASDAQ:CTIC) stock traded during its last trading session with the total traded volume of 6,802,079 shares versus its average volume of 2.80 million shares. The company opened its trade at the price of $2.41 and its closing price was $2.37 after losing -4.44% for the day. Cell Therapeutics, Inc. acquires, develops, and commercializes treatments for cancer. The company primary focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in Phase III clinical trials for the treatment of multiply relapsed or refractory aggressive non-Hodgkin lymphoma.
Will CTIC Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)